Treatment with disease‐modifying drugs for people with a first clinical attack suggestive of multiple sclerosis

G Filippini, C Del Giovane, M Clerico… - Cochrane database …, 2017 - cochranelibrary.com
Background The treatment of multiple sclerosis has changed over the last 20 years. The
advent of disease‐modifying drugs in the mid‐1990s heralded a period of rapid progress in …

[PDF][PDF] Treatment with disease modifying drugs for people with a first clinical attack suggestive of multiple sclerosis

G Filippini, M Clerico, O Beiki, M Mattoscio… - status and date: New …, 2016 - academia.edu
This is the protocol for a review and there is no abstract. The objectives are as follows:• To
estimate the benefit and safety of all DMDs that have been evaluated in all studies …

[PDF][PDF] Treatment with disease-modifying drugs for people with a first clinical attack suggestive of multiple sclerosis.

G Filippini, C Del Giovane, M Clerico… - Cochrane database of …, 2017 - boris.unibe.ch
BACKGROUND The treatment of multiple sclerosis has changed over the last 20 years. The
advent of disease-modifying drugs in the mid-1990s heralded a period of rapid progress in …

Treatment with disease-modifying drugs for people with a first clinical attack suggestive of multiple sclerosis.

G Filippini, C Del Giovane, M Clerico… - The Cochrane …, 2017 - europepmc.org
Background The treatment of multiple sclerosis has changed over the last 20 years. The
advent of disease-modifying drugs in the mid-1990s heralded a period of rapid progress in …

[PDF][PDF] Treatment with disease-modifying drugs for people with a first clinical attack suggestive of multiple sclerosis

G Filippini, C Del Giovane, M Clerico, O Beiki… - status and date: New …, 2017 - core.ac.uk
Background The treatment of multiple sclerosis has changed over the last 20 years. The
advent of disease-modifying drugs in the mid-1990s heralded a period of rapid progress in …

[HTML][HTML] Treatment with disease‐modifying drugs for people with a first clinical attack suggestive of multiple sclerosis

G Filippini, C Del Giovane, M Clerico… - The Cochrane …, 2017 - ncbi.nlm.nih.gov
Background The treatment of multiple sclerosis has changed over the last 20 years. The
advent of disease‐modifying drugs in the mid‐1990s heralded a period of rapid progress in …

[HTML][HTML] Treatment with disease-modifying drugs for people with a first clinical attack suggestive of multiple sclerosis.

G Filippini, C Del Giovane, M Clerico, O Beiki… - The Cochrane database …, 2017 - sonar.ch
OBJECTIVES 1. to estimate the benefit and safety of disease-modifying drugs that have
been evaluated in all studies (randomised or non-randomised) for the treatment of a first …

Treatment with disease-modifying drugs for people with a first clinical attack suggestive of multiple sclerosis

G Filippini, C Del Giovane, M Clerico, O Beiki… - COCHRANE …, 2017 - iris.unimore.it
Background: The treatment of multiple sclerosis has changed over the last 20 years. The
advent of disease-modifying drugs in the mid-1990s heralded a period of rapid progress in …

Treatment with disease-modifying drugs for people with a first clinical attack suggestive of multiple sclerosis

G Filippini, C Del Giovane, M Clerico… - The Cochrane …, 2017 - pubmed.ncbi.nlm.nih.gov
Background The treatment of multiple sclerosis has changed over the last 20 years. The
advent of disease-modifying drugs in the mid-1990s heralded a period of rapid progress in …

Treatment with disease-modifying drugs for people with a first clinical attack suggestive of multiple sclerosis

G Filippini, C Del Giovane, M Clerico, O Beiki… - COCHRANE …, 2017 - iris.unito.it
The treatment of multiple sclerosis has changed over the last 20 years. The advent of
disease-modifying drugs in the mid-1990s heralded a period of rapid progress in the …